TABLE OF CONTENTS
REGULATORY
Drug Delivery Systems for Administration of Inhaled Therapies in Patients with Chronic Obstructive Pulmonary Disease Myrna B. Dolovich, PEng
CLINICAL
Delivery System Selection: Clinical Considerations Robert Filuk, MD, FRCPC, FACP, FCCP
BUSINESS
Economic Considerations in Chronic Obstructive Pulmonary Disease Treatment James T. Kenney, Jr, RPh, MBA